June 30, 2023
The U.S. Supreme Court on Friday told the Fourth and Eleventh circuits to revisit closely watched whistleblower cases targeting units of Allergan and Abbott Laboratories, teeing up tests of the high court's new ruling on the meaning of intentional fraud under the False Claims Act.
October 24, 2022
False Claims Act cases targeting erroneous yet reasonable views of compliance duties have produced an acrimonious "muddle" in the nation's circuit courts, a whistleblowing former executive told the U.S. Supreme Court, which is already signaling interest in the law's disputed standards for intentional overbilling.